Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Samuel Granjeaud

Showing results (51-60 of 67) with videos related to

Pageof 7
Sort By:
Cancer Research|December 23, 2017
LIF Drives Neural Remodeling in Pancreatic Cancer and Offers a New Candidate BiomarkerChristian Bressy, Sophie Lac, Jérémy Nigri, et al.
Frontiers in Immunology|May 22, 2018
Immunomodulatory Drugs Exert Anti-Leukemia Effects in Acute Myeloid Leukemia by Direct and Immunostimulatory ActivitiesAude Le Roy, Thomas Prébet, Rémy Castellano, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 27, 2022
Mass Cytometry Reveals Classical Monocytes, NK Cells, and ICOS+ CD4+ T Cells Associated with Pembrolizumab Efficacy in Patients with Lung CancerPhilippe Rochigneux, Aaron Lisberg, Alejandro Garcia, et al.
Oncotarget|October 19, 2018
Development of parallel reaction monitoring (PRM)-based quantitative proteomics applied to HER2-Positive breast cancerMathilde Guerin, Anthony Gonçalves, Yves Toiron, et al.
Cancer Immunology Research|January 31, 2025
Tertiary Lymphoid Structures Are Associated with Enhanced Macrophage Activation and Immune Checkpoint Expression and Predict Outcome in Cervical CancerLaurent Gorvel, Marylou Panouillot, Marie-Sarah Rouvière, et al.
Oncotarget|September 20, 2019
Correction: NKp30 expression is a prognostic immune biomarker for stratification of patients with intermediate-risk acute myeloid leukemiaAnne-Sophie Chretien, Cyril Fauriat, Florence Orlanducci, et al.
Blood|November 25, 2003
Small lymphocytic lymphoma, marginal zone B-cell lymphoma, and mantle cell lymphoma exhibit distinct gene-expression profiles allowing molecular diagnosisCatherine Thieblemont, Valéry Nasser, Pascale Felman, et al.
Oncotarget|May 27, 2017
NKp30 expression is a prognostic immune biomarker for stratification of patients with intermediate-risk acute myeloid leukemiaAnne-Sophie Chretien, Cyril Fauriat, Florence Orlanducci, et al.
Cancer Research|October 4, 2017
JAM-C Identifies Src Family Kinase-Activated Leukemia-Initiating Cells and Predicts Poor Prognosis in Acute Myeloid LeukemiaMaria De Grandis, Florence Bardin, Cyril Fauriat, et al.
Cancer Research|June 28, 2023
CD25high Effector Regulatory T Cells Hamper Responses to PD-1 Blockade in Triple-Negative Breast CancerStéphane Fattori, Aude Le Roy, Jemila Houacine, et al.
Pageof 7

Showing results (51-60 of 67) with videos related to

Sort By:
Pageof 7
Cancer Research|December 23, 2017
LIF Drives Neural Remodeling in Pancreatic Cancer and Offers a New Candidate BiomarkerChristian Bressy, Sophie Lac, Jérémy Nigri, et al.
Frontiers in Immunology|May 22, 2018
Immunomodulatory Drugs Exert Anti-Leukemia Effects in Acute Myeloid Leukemia by Direct and Immunostimulatory ActivitiesAude Le Roy, Thomas Prébet, Rémy Castellano, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 27, 2022
Mass Cytometry Reveals Classical Monocytes, NK Cells, and ICOS+ CD4+ T Cells Associated with Pembrolizumab Efficacy in Patients with Lung CancerPhilippe Rochigneux, Aaron Lisberg, Alejandro Garcia, et al.
Oncotarget|October 19, 2018
Development of parallel reaction monitoring (PRM)-based quantitative proteomics applied to HER2-Positive breast cancerMathilde Guerin, Anthony Gonçalves, Yves Toiron, et al.
Cancer Immunology Research|January 31, 2025
Tertiary Lymphoid Structures Are Associated with Enhanced Macrophage Activation and Immune Checkpoint Expression and Predict Outcome in Cervical CancerLaurent Gorvel, Marylou Panouillot, Marie-Sarah Rouvière, et al.
Oncotarget|September 20, 2019
Correction: NKp30 expression is a prognostic immune biomarker for stratification of patients with intermediate-risk acute myeloid leukemiaAnne-Sophie Chretien, Cyril Fauriat, Florence Orlanducci, et al.
Blood|November 25, 2003
Small lymphocytic lymphoma, marginal zone B-cell lymphoma, and mantle cell lymphoma exhibit distinct gene-expression profiles allowing molecular diagnosisCatherine Thieblemont, Valéry Nasser, Pascale Felman, et al.
Oncotarget|May 27, 2017
NKp30 expression is a prognostic immune biomarker for stratification of patients with intermediate-risk acute myeloid leukemiaAnne-Sophie Chretien, Cyril Fauriat, Florence Orlanducci, et al.
Cancer Research|October 4, 2017
JAM-C Identifies Src Family Kinase-Activated Leukemia-Initiating Cells and Predicts Poor Prognosis in Acute Myeloid LeukemiaMaria De Grandis, Florence Bardin, Cyril Fauriat, et al.
Cancer Research|June 28, 2023
CD25high Effector Regulatory T Cells Hamper Responses to PD-1 Blockade in Triple-Negative Breast CancerStéphane Fattori, Aude Le Roy, Jemila Houacine, et al.
Pageof 7